Cytogenetic risk groups in acute myeloblastic leukaemia differ greatly in their semi‐solid colony growth

No abstract is available for this paper.

• Publication year

  2001

• Venue

  British Journal of Haematology

• Publication date

  2001-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2141.2001.02698.xPMID 11328291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International System for Human Cytogenetic Nomenclature

  2020cited by this paper
• Applied Logistic Regression: Hosmer/Applied Logistic Regression

  2005cited by this paper
• Treatment of acute leukemia.

  1999cited by this paper
• The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

  1998cited by this paper
• Classical and Molecular Cytogenetics

  1998cited by this paper
• In vitro growth in acute myeloblastic leukaemia: relationship with other clinico‐biological characteristics of the disease

  1998cited by this paper
• Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release.

  1997cited by this paper
• Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

  1997cited by this paper
• A note on quantifying follow-up in studies of failure time.

  1996cited by this paper
• Interleukin 10 inhibits growth and granulocyte/macrophage colony- stimulating factor production in chronic myelomonocytic leukemia cells

  1996cited by this paper
• Models of T cell anergy: is there a common molecular mechanism?

  1996cited by this paper
• Multidrug resistant cells with high proliferative capacity determine response to therapy in acute myeloid leukemia.

  1995cited by this paper
• Chromosomal translocations in human cancer

  1994cited by this paper
• Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells.

  1994cited by this paper
• Absence of retinoblastoma protein expression results in autocrine production of interleukin-6 and promotes the autonomous growth of acute myeloid leukemia blast cells.

  1994cited by this paper
• Regulation of Bcl-2 expression and apoptosis in acute myeloblastic leukaemia cells by granulocyte-macrophage colony-stimulating factor.

  1994cited by this paper
• Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics.

  1993cited by this paper
• Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia.

  1993cited by this paper
• Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia.

  1993cited by this paper
• Heterogenous mechanisms of autocrine growth of AML blasts

  1989cited by this paper
• Chromosome abnormalities in acute nonlymphocytic leukemia: clinical and biologic significance.

  1987cited by this paper
• Autocrine secretion of GM-CSF in acute myeloblastic leukemia.

  1986cited by this paper
• A simplified in vitro classification for prognosis in adult acute leukemia: the application of in vitro results in remission-predictive models.

  1976cited by this paper
• Agar culture studies in 127 cases of untreated acute leukemia: the prognostic value of reclassification of leukemia according to in vitro growth characteristics.

  1974cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper

• Impact of Cytogenetics on Clinical Outcome in AML

  2007cites this paper
• Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis.

  2006cites this paper
• Expression of β-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis

  2006cites this paper
• Biology and management of relapsed acute myeloid leukaemia

  2005cites this paper
• Clonogenic growth patterns correlate with chemotherapy response in acute myeloid leukaemia

  2005cites this paper
• Diagnostic and prognostic value of colony formation of hematopoietic progenitor cells in myeloid malignancies

  2003cites this paper
• Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes

  2003cites this paper
• Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasia.

  2003cites this paper
• Relation of In Vitro Growth Characteristics to Cytogenetics and Treatment Outcome in Acute Myeloid Leukemia: Prognostic Significance in Patients with a Normal Karyotype

  2003cites this paper
• Semi-solid Colony Growth in Acute Myeloid Leukemia and its Relation to Cytogenetic Risk Groups

  2002cites this paper
• The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia.

  2001cites this paper
• The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

  2001cites this paper